Form 4 for CBIO CRESCENT BIOPHARMA, INC.
Accepted 2024-06-24 00:00:00 ET · period of report 2024-06-20 · accession 0001415889-24-017978 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-24 | 2024-06-20+ | CBIO | Rock Edwin | Chief Medical Off | P - Purchase | $0.2575 | +305.0K | 680.4K | +81% | +$78.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-20 | P | A | 190,000 | $0.25 | 565,403 | D | — | — | (F1) The Reporting Person purchased the securities on the open market at purchase prices ranging from $0.24 to $0.2594 per share, with a weighted average purchase price of $0.2532 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2024-06-21 | P | A | 115,000 | $0.27 | 680,403 | D | — | — | (F2) The Reporting Person purchased the securities on the open market at purchase prices ranging from $0.2579 to $0.27 per share, with a weighted average purchase price of $0.2671 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |